TORONTO, Nov. 20 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that Gamma-Dynacare Medical Laboratories, leading providers of laboratory services, information and products in Canada, will provide blood specimen collection services for ColonSentry(TM), the world's first blood-based test to determine a person's current risk for colorectal cancer, from an expanded number of laboratory patient service centres in the Toronto area.
"We are very pleased to be working with Gamma-Dynacare as it is one of Canada's largest and most respected providers of medical laboratory services. Gamma-Dynacare is committed to bringing the next generation of medical diagnostic tests to Canadians and ColonSentry(TM) will complement their menu of leading-edge offerings," said Gailina Liew, Chief Operating Officer of GeneNews. "The addition of these sites in the Toronto area will provide a far greater number of patients access to our unique test, an important factor as we continue to drive awareness and increase clinical and patient adoption of the ColonSentry(TM) test."
"Colorectal cancer is the second deadliest cancer in Canada, but is highly curable when detected early. The ColonSentry(TM) test represents a new approach to colorectal cancer screening that is more convenient for patients as the test only requires a simple blood sample," said Ron Hoffman, Vice-President, Business Development, Gamma-Dynacare Medical Laboratories. "We look forward to expanding access to the ColonSentry(TM) test in additional locations in south-western Ontario and Quebec over the next few months. We believe the convenience of this test will result in more patients being screened and we are proud to be the first community laboratory in Canada to assist GeneNews in the introduction of ColonSentry(TM)."
"Gamma-Dynacare is currently offering specimen collection services for the ColonSentry(TM) test at the following eight Patient Service Centre locations that are listed below. GeneNews and Gamma-Dynacare expect to expand availability of ColonSentry(TM) to more Gamma-Dynacare locations in Ontario and Quebec over the first quarter of 2009."
1. 2401 Yonge St., Suite LL9 (Yonge St. & Eglinton Ave.) Toronto, Ontario, M4P 3H1 Hours of operation: Monday - Thursday 8:00 AM to 8:00 PM Friday 8:00 AM to 3:00 PM 2. 123 Edward St., Suite 808 (University and Dundas) Toronto, Ontario, M5G 1E2 Hours of operation: Monday - Thursday 8:00 AM to 6:00 PM Friday 8:00 AM to 3:00 PM 3. 328 Highway 7 East, Suite 210 (Bayview and Highway #7) Richmond Hill, Ontario, L4B 3P7 Hours of operation: Monday - Thursday 8:00 AM to 5:00 PM Friday 8:00 AM to 3:00 PM 4. 5359 Dundas Street West, Suite 200 (Bloor St. W. and Dundas St. W.) Etobicoke, Ontario, M9B 6H8 Hours of operation: Monday - Friday 9:00 AM to 12:00 PM 5. 960 Lawrence Avenue West, Suite 102 (Lawrence St. W. and Dufferin St.) Toronto, Ontario, M6A 3B5 Hours of operation: Monday - Thursday 8:00 AM to 6:00 PM Friday 8:00 AM to 3:00 PM 6. 2000 Credit Valley Rd., Suite 107 (Credit Valley Road and Eglinton Ave W.) Mississauga, ON L5M 4N4 Hours of operation: Monday - Thursday 7:00 AM to 8:00 PM Friday 7:00 AM to 3:00 PM 7. 164 Queen St. E., Main Floor (Queen St. East and Kennedy Road South) Brampton, ON L6V 1B4 Hours of operation: Monday - Thursday 7:00 AM to 5:00 PM Friday: 8:00 AM to 3:00 PM 8. 95 Bayly Street West, Unit 208, Ajax, ON L1S 7K8 Hours of operation: Monday, Tuesday and Thursday 8:00 AM to 7:00 PM Wednesday 8:00 AM to 5:00 PM Friday 8:00 AM to 3:00 PM About Gamma-Dynacare Medical Laboratories -----------------------------------------
Gamma-Dynacare is one of Canada's largest and most respected providers of laboratory services and solutions. Our skilled and dedicated employees perform millions of tests each year in our state-of-the-art facilities, playing a key role in the treatment of patients and the prevention and diagnosis of disease. By living our mission of "Caring for People", we positively impact the health and wellness of people across Canada and are a valuable contributor to the betterment of the overall healthcare system. For additional information please visit www.gamma-dynacare.com.
About GeneNews --------------
GeneNews is focused on the application of functional genomics to enable early diagnosis and personalized therapeutic intervention based on disease-specific biomarkers. The Company has developed a novel approach, the Sentinel Principle(TM), to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle(TM) in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. For more information on GeneNews, visit www.genenews.com.
This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.
|SOURCE GeneNews Limited|
Copyright©2008 PR Newswire.
All rights reserved